Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway

Xuemei Liu(Chongqing Medical and Pharmaceutical College), Changhua Hu(Ningbo No.6 Hospital)
Acta Pharmacologica Sinica
February 6, 2019
Cited by 29


Related Papers